461 related articles for article (PubMed ID: 2142441)
1. Graft-versus-host disease associated T helper cell responses specific for minor histocompatibility antigens are mainly restricted by HLA-DR molecules.
van Els CA; Zantvoort E; Jacobs N; Bakker A; van Rood JJ; Goulmy E
Bone Marrow Transplant; 1990 Jun; 5(6):365-72. PubMed ID: 2142441
[TBL] [Abstract][Full Text] [Related]
2. Generation of self HLA-DR-specific CD3+CD4-CD8+ cytotoxic T cells in chronic graft-versus-host disease.
Yamamoto M; Sugihara K; Ohtsuki F; Tsujino Y; Tanaka A; Kamiya T; Wada H; Kanamaru A; Hara H; Yano A
Bone Marrow Transplant; 1994 Oct; 14(4):525-33. PubMed ID: 7858527
[TBL] [Abstract][Full Text] [Related]
3. Autologous B lymphoblastoid cell lines and long-term cultured T cells as stimulators in the mixed lymphocyte reaction: analysis of the role of HLA class II antigens as stimulatory molecules.
Santoli D; Radka SF; Igarashi M; Kreider BL; Ferrone S
J Immunol; 1986 Jul; 137(2):400-7. PubMed ID: 2941479
[TBL] [Abstract][Full Text] [Related]
4. Lethal graft-versus-host disease in mice directed to multiple minor histocompatibility antigens: features of CD8+ and CD4+ T cell responses.
Korngold R
Bone Marrow Transplant; 1992 May; 9(5):355-64. PubMed ID: 1352163
[TBL] [Abstract][Full Text] [Related]
5. Minor histocompatibility antigens, defined by graft-vs.-host disease-derived cytotoxic T lymphocytes, show variable expression on human skin cells.
De Bueger M; Bakker A; Van Rood JJ; Goulmy E
Eur J Immunol; 1991 Nov; 21(11):2839-44. PubMed ID: 1682155
[TBL] [Abstract][Full Text] [Related]
6. Two distinct class II molecules encoded by the genes within HLA-DR subregion of HLA-Dw2 and Dw12 can act as stimulating and restriction molecules.
Sone T; Tsukamoto K; Hirayama K; Nishimura Y; Takenouchi T; Aizawa M; Sasazuki T
J Immunol; 1985 Aug; 135(2):1288-98. PubMed ID: 3159789
[TBL] [Abstract][Full Text] [Related]
7. Requirement of Ia-positive accessory cells in the MLR response against class II antigen on human B cell tumor line.
Yamamoto M; Yano A
J Immunol; 1985 Dec; 135(6):3887-96. PubMed ID: 2999233
[TBL] [Abstract][Full Text] [Related]
8. Differential presentation of HLA-DR, DQ, and DP restriction elements by interferon-gamma-treated dermal fibroblasts.
Maurer DH; Hanke JH; Mickelson E; Rich RR; Pollack MS
J Immunol; 1987 Aug; 139(3):715-23. PubMed ID: 3110281
[TBL] [Abstract][Full Text] [Related]
9. Multiple minor histocompatibility antigen-specific cytotoxic T lymphocyte clones can be generated during graft rejection after HLA-identical bone marrow transplantation.
Marijt WA; Kernan NA; Diaz-Barrientos T; Veenhof WF; O'Reilly RJ; Willemze R; Falkenburg JH
Bone Marrow Transplant; 1995 Jul; 16(1):125-32. PubMed ID: 7581111
[TBL] [Abstract][Full Text] [Related]
10. T cell subsets involved in lethal graft-versus-host disease directed to immunodominant minor histocompatibility antigens.
Berger M; Wettstein PJ; Korngold R
Transplantation; 1994 Apr; 57(7):1095-102. PubMed ID: 7909395
[TBL] [Abstract][Full Text] [Related]
11. A human autoreactive T cell line specific for minor histocompatibility antigen(s) isolated from a bone marrow-grafted patient.
Tilkin AF; Bagot M; Kayibanda M; Vernant JP; Levy JP
J Immunol; 1986 Dec; 137(12):3772-6. PubMed ID: 3537123
[TBL] [Abstract][Full Text] [Related]
12. Class II major histocompatibility complex restriction of human T cell responses to short ragweed allergen, Amb a V.
Huang SK; Zwollo P; Marsh DG
Eur J Immunol; 1991 Jun; 21(6):1469-73. PubMed ID: 2044656
[TBL] [Abstract][Full Text] [Related]
13. Specific donor Vbeta-associated CD4 T-cell responses correlate with severe acute graft-versus-host disease directed to multiple minor histocompatibility antigens.
Jones SC; Friedman TM; Murphy GF; Korngold R
Biol Blood Marrow Transplant; 2004 Feb; 10(2):91-105. PubMed ID: 14750075
[TBL] [Abstract][Full Text] [Related]
14. Parasite antigen-specific human T cell lines and clones. Major histocompatibility complex restriction and B cell helper function.
Nutman TB; Ottesen EA; Fauci AS; Volkman DJ
J Clin Invest; 1984 Jun; 73(6):1754-62. PubMed ID: 6233302
[TBL] [Abstract][Full Text] [Related]
15. Alloreactivity and the predictive value of anti-recipient specific interleukin 2 producing helper T lymphocyte precursor frequencies for alloreactivity after bone marrow transplantation.
Russell CA
Dan Med Bull; 2002 May; 49(2):89-108. PubMed ID: 12064093
[TBL] [Abstract][Full Text] [Related]
16. Measurement of recipient-specific alloreactivity: is GVHD predictable?
Theobald M; Bunjes D; Nierle T; Arnold R; Heimpel H
Bone Marrow Transplant; 1993; 12 Suppl 3():S18-23. PubMed ID: 8124251
[TBL] [Abstract][Full Text] [Related]
17. Cloned allospecific human helper T cell lines induce an MHC-restricted proliferative response by resting B cells.
Goldberg D; Green A; Gottlieb AB; Crow MK; Lewison A; Friedman SM
J Immunol; 1985 Aug; 135(2):1012-9. PubMed ID: 2409133
[TBL] [Abstract][Full Text] [Related]
18. Allorecognition of HLA-DR and -DQ transfectants by human CD45RA and CD45R0 CD4 T cells: repertoire analysis and activation requirements.
Merkenschlager M; Ikeda H; Wilkinson D; Beverly PC; Trowsdale J; Fisher AG; Altmann DM
Eur J Immunol; 1991 Jan; 21(1):79-88. PubMed ID: 1671359
[TBL] [Abstract][Full Text] [Related]
19. Proliferative T cell clones directed at a human minor antigen.
Zier KS
Exp Clin Immunogenet; 1985; 2(1):36-42. PubMed ID: 2978829
[TBL] [Abstract][Full Text] [Related]
20. T cell alloresponses against HLA-DQ and -DR products involve multiple epitopes on the CD4 molecule. Distinct mechanisms contribute to the inhibition of HLA class II-dependent and -independent T cell responses by antibodies to CD4.
Merkenschlager M; Altmann DM; Ikeda H
J Immunol; 1990 Nov; 145(10):3181-7. PubMed ID: 1699999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
